foscarnet has been researched along with Histiocytosis, Non-Langerhans-Cell in 3 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Histiocytosis, Non-Langerhans-Cell: Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this report we describe the effects of foscarnet on HHV-8 viremia in an HIV-infected patient with disseminated Kaposi s sarcoma and a presumably HHV-8 associated hemophagocytic syndrome." | 7.70 | Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. ( Fleckenstein, B; Harrer, T; Kalden, JR; Löw, P; Manger, B; Neipel, F; Rascu, A; Steininger, H, 1998) |
| " In this report we describe the effects of foscarnet on HHV-8 viremia in an HIV-infected patient with disseminated Kaposi s sarcoma and a presumably HHV-8 associated hemophagocytic syndrome." | 3.70 | Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. ( Fleckenstein, B; Harrer, T; Kalden, JR; Löw, P; Manger, B; Neipel, F; Rascu, A; Steininger, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Löw, P | 1 |
| Neipel, F | 1 |
| Rascu, A | 1 |
| Steininger, H | 1 |
| Manger, B | 1 |
| Fleckenstein, B | 1 |
| Kalden, JR | 1 |
| Harrer, T | 1 |
| Johnston, RE | 1 |
| Geretti, AM | 1 |
| Prentice, HG | 1 |
| Clark, AD | 1 |
| Wheeler, AC | 1 |
| Potter, M | 1 |
| Griffiths, PD | 1 |
| Lortholary, A | 1 |
| Raffi, F | 1 |
| Aubertin, P | 1 |
| Barrier, JH | 1 |
| Boibieux, A | 1 |
| Peyramond, D | 1 |
3 other studies available for foscarnet and Histiocytosis, Non-Langerhans-Cell
| Article | Year |
|---|---|
Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA, Viral; Foscarnet; Herpesvirus 8 | 1998 |
HHV-6-related secondary graft failure following allogeneic bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Diseases; Bone Marrow Transplantation; Child; Diagnosis, Differential; | 1999 |
HIV-associated haemophagocytic syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Antiviral Agents; Drug Therapy, Co | 1990 |